<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rdf:RDF
	xmlns="http://purl.org/rss/1.0/"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel rdf:about="http://www.farmavita.net">
		<title>Farmavita.Net - Pharmaceutical Licensing Network</title>
		<description>Farmavita.Net is network for pharmaceutical licensing and regulatory affairs.</description>
		<link>http://www.farmavita.net</link>
		<image rdf:resource="http://www.farmavita.net/images/M_images/rss20.gif" />
	   <dc:date>2009-07-04T04:42:24+01:00</dc:date>
		<items>
			<rdf:Seq>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1173/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1172/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1169/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1168/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/877/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1166/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1162/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1152/120/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1151/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1149/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1148/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1147/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1146/120/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1145/84/"/>
				<rdf:li rdf:resource="http://www.farmavita.net/content/view/1144/84/"/>
			</rdf:Seq>
		</items>
	</channel>
	<image rdf:about="http://www.farmavita.net/images/M_images/rss20.gif">
		<title>Farmavita.Net - RSS Feed</title>
		<link>http://www.farmavita.net</link>
		<url>http://www.farmavita.net/images/M_images/rss20.gif</url>
	</image>
	<item rdf:about="http://www.farmavita.net/content/view/1173/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-30T11:02:50+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>In-licencing Opportunities</title>
		<link>http://www.farmavita.net/content/view/1173/84/</link>
		<description>
Amaze, Ltd, a Portuguese Consultancy Company for Pharma Business Development activities is looking for OTC products to a local new company. 


We have also a partner looking for ethic products either for CNS or Cardiovascular areas. 


For more informations please contact Farmavita.Net team.

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1172/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-29T13:26:20+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Business opportunities in Portugal</title>
		<link>http://www.farmavita.net/content/view/1172/84/</link>
		<description>
AMAZE, Ltd,a Portuguese Consultancy Company acting in Pharma Business Development is looking for in-licensing opportunities to our local clients. 


We are seeking for OTC and ethic products in order to support our local pharma activities. 


For more informations please contact Farmavita.Net team. 


 


 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1169/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-26T07:31:13+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Tacrolimus capsules</title>
		<link>http://www.farmavita.net/content/view/1169/84/</link>
		<description>
Farmavita.Net member is looking for tacrolimus hard capsules with the BE study matching narrow limits both for the AUC and Cmax (90-111%), fed and fasted.

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1168/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-26T07:28:58+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Medis International a.s.</title>
		<link>http://www.farmavita.net/content/view/1168/84/</link>
		<description>Primary and secondary packaging of drug products including EU batch release.
</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/877/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-25T01:00:00+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Drotaverine</title>
		<link>http://www.farmavita.net/content/view/877/84/</link>
		<description>License-in needs for DROTAVERINE 





Client of Farmavita.Net is looking for EU CTD Dossier with bulk supply of  40mg/80mg tablets of drotaverin hydrochloride. 


License territory would be Poland. Licensee is established company with well developed sales and distribution capability.   

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1166/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-24T03:45:11+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Agency and distribution partership</title>
		<link>http://www.farmavita.net/content/view/1166/84/</link>
		<description>Agency and distribution partership for branded medicines in China



Farmavita.Net member is  looking for long-term agency and distribution partership of branded anticancer or cardiovascular medicines in China. Neptunus Group was established in 1989, and now it has been one of the famous brands of the health industry in China, the comprehensive competitiveness of which ranks the top in the pharmaceutical industry in China. 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1162/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-06-08T10:57:51+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Herbal Treatment of Malaria</title>
		<link>http://www.farmavita.net/content/view/1162/84/</link>
		<description>
MALARIA: AN OVERVIEW WITH HERBAL TREATMENT 

The success of the antimalarial drug quinine and the discovery of artemisinin, the most potent antimalarial drug, both from plant sources, has led to the study of plants as antimalarial agents. The ethnopharmacological approach for the search of new antimalarial agents from plant sources has proved to be more predictive. In India the National Malaria Eradication Programme (NMEP), started in 1958, achieved near complete disappearance of the disease in 1960s. 


The whole 34 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,86/) section of Faramavita.Net 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1152/120/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-29T10:07:18+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Looking for Strategic Investor</title>
		<link>http://www.farmavita.net/content/view/1152/120/</link>
		<description>API Manufacturer from India - Looking for Strategic Investor 

Company was estabilished in the year 2004 by a group of technocrats from renowned Dr.Reddys Laboratories Limited. All the key personnel have expertise in their respective areas of specialization. Strong R D, Analytical capabilities, versatile human resources and well vision management are the core competencies of the company. 
Today the Group is operating with one Intermediate manufacturing unit and one API manufacturing unit both are located in Pashamylaram IDA, 25 KMs away from Hyderabad. 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1151/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-25T10:22:22+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Cefuroxime Axetil</title>
		<link>http://www.farmavita.net/content/view/1151/84/</link>
		<description>
FORMULATION AND EVALUATION OF FLOATING TABLETS OF CEFUROXIME AXETIL

The aim of the present work was to design and development of hydrodynamically balanced tablet of cefuroxime axetil to enhance the bioavailability and therapeutic efficacy of the drug. Cefuroxime axetil is classified as a second-generation cephalosporin antibiotic and beta lactum antibiotics based on spectrum activity. Tablets are prepared by the direct compression technique by using HPMC K4M and mannitol as polymers along with sodium bi carbonate as gas generating agent. Formulation were evaluated for in vitro byoyancy and drug release study using up dissolation apparatus using 0.1N Hcl as a medium.The result indicate that floating tablets of dissolation cefuroxime axetil containg 45mg HPMC K4M provides a better option for control release action and improved bioavailability. 


The whole 8 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,85/) section of Faramavita.Net 


 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1149/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-22T11:41:26+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Treatment of Parkinson's Disease</title>
		<link>http://www.farmavita.net/content/view/1149/84/</link>
		<description>
RECENT TRENDS IN DRUGS USED FOR TREATMENT OF PARKINSON'S DISEASE

Parkinson's disease is a disease of the nervous system that causes people to lose control over their muscles. About one in every 250 people over the age of 40, and about one in every 100 people aged 65 or older, are affected by Parkinson's disease. Although the average age of onset is 57, Parkinson's occasionally appears in childhood. Men are more likely to develop Parkinson's than women. In itself, Parkinson's is not a fatal condition. 


The whole 12 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,84/) section of Faramavita.Net 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1148/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-22T10:23:55+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Treatment of Asthma</title>
		<link>http://www.farmavita.net/content/view/1148/84/</link>
		<description>
DRUG USED IN TREATMENT OF ASTHMA

Asthma is a disease that affects the breathing passages of the lungs (bronchioles). Asthma is caused by chronic (ongoing, long-term) inflammation of these passages. This makes the breathing passages, or airways, of the person with asthma highly sensitive to various  triggers. When the inflammation is  triggered  by any number of external and internal factors, the passages swell and fill with mucus. Muscles within the breathing passages contract (bronchospasm), causing even further narrowing of the airways. This narrowing makes it difficult for air to be breathed out (exhaled) from the lungs. This resistance to exhaling leads to the typical symptoms of an asthma attack. 


The whole 16 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,83/) section of Faramavita.Net 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1147/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-20T09:47:02+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Bacterial Meningitis</title>
		<link>http://www.farmavita.net/content/view/1147/84/</link>
		<description>A COMPREHENSIVE REVIEW ON BACTERIAL MENINGITIS

Bacterial meningitis is found worldwide. The bacteria often live harmlessly in a person's mouth and throat. In rare instances, however, they can break through the body's immune defenses and travel to the fluid surrounding the brain and spinal cord. There they begin to multiply quickly. Soon, the thin membrane that covers the brain and spinal cord (meninges) becomes swollen and inflamed, leading to the classic symptoms of meningitis. The bacteria are spread by direct close contact with the discharges from the nose or throat of an infected person. 


The whole 11 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,82/) section of Faramavita.Net 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1146/120/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-19T10:49:27+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Turkey - Company for Sale</title>
		<link>http://www.farmavita.net/content/view/1146/120/</link>
		<description>
Turkey - Pharmaceutical Company for Sale

Outside the BRIC (Brazil, Russia, India, China) states, Turkey is considered one of the key growth pharmaceutical markets globally. Growth has been rapid in recent years, with per capita spending reaching US$159 in 2008, a similar level to other emerging countries in Eastern Europe. The country's large, ageing and increasingly urbanised population, means both demand and access to medicines should increase in the future. Over the next five years, sales of pharmaceuticals, which include prescription drugs and over-the-counter (OTC) medicines, will increase from US$11.3bn to US$19.5bn, representing a compound annual growth rate (CAGR) of 11.6%. 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1145/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-18T15:09:32+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Food Quality</title>
		<link>http://www.farmavita.net/content/view/1145/84/</link>
		<description>
MICROBIAL AND CHEMICAL FACTORS INVOLVED IN DETERIORATION OF FOOD QUALITY: AN OVERVIEW

Foods consumed by man and animals are ideal ecosystems in which bacteria and fungi can multiply. The mere presence of microorganisms in foods in small numbers however, need not be harmful, but their unrestricted growth may render the food unfit for consumption and can result in spoilage or deterioration. Knowledge of the factors that either favour or inhibit their growth is therefore, essential in understanding the principles of food spoilage and preservation. The present paper enumerates the various aspects of microbial and chemical factors involved in the deterioration of food quality. 


The whole 11 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,81/) section of Faramavita.Net 

</description>
	</item>
	<item rdf:about="http://www.farmavita.net/content/view/1144/84/">
		<dc:format>text/html</dc:format>
		<dc:date>2009-05-18T14:37:23+01:00</dc:date>
		<dc:source>http://www.farmavita.net</dc:source>
		<title>Microbiological assays</title>
		<link>http://www.farmavita.net/content/view/1144/84/</link>
		<description>
A REVIEW ON MICROBIOLOGIAL ASSAY

Microbiological assays are designed to perform the qualitative and quantitative estimations of specific viable microorganisms present in the samples. The test should be performed in all the samples to ensure that the it is free from any micro-organism and it also ensure that it will not going to harm the human body as concern to the micro-organism. 


The whole 10 pages article is available for download at Downloads (http://www.farmavita.net/component/option,com_remository/Itemid,88/func,fileinfo/id,80/) section of Faramavita.Net 

</description>
	</item>
</rdf:RDF>
